[1]杨 凯,朱悦琦,程英升.食管良性狭窄药物镁合金可降解支架研究现状及展望[J].介入放射学杂志,2015,(05):452-455.
 YANG Kai,ZHU Yue qi,CHENG Ying sheng.The application of drug eluting biodegradable magnesium alloy stent in treating esophageal benign stricture: current research status and prospect[J].journal interventional radiology,2015,(05):452-455.
点击复制

食管良性狭窄药物镁合金可降解支架研究现状及展望()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2015年05期
页码:
452-455
栏目:
综述
出版日期:
2015-05-25

文章信息/Info

Title:
The application of drug eluting biodegradable magnesium alloy stent in treating esophageal benign stricture: current research status and prospect
作者:
杨 凯 朱悦琦 程英升
Author(s):
YANG Kai ZHU Yue qi CHENG Ying sheng
Department of Radiology, Shanghai Sixth People’s Hospital, Shanghai Jiaotong University, Shanghai 200233, China
关键词:
【关键词】 食管支架 可降解 镁合金 食管良性狭窄
文献标志码:
A
摘要:
【摘要】 支架在食管良性狭窄的治疗中发挥着越来越重要的作用。临床应用的支架主要为金属支架,可分为永久性支架和暂时性可回收支架。永久性金属支架长期植入易引起炎性增生、支架内再狭窄、穿孔、出血等并发症,暂时性可回收金属支架植入后1周内需取出,以避免食管瘢痕修复及支架内组织增生导致其取出困难、远期食管再狭窄复发率高。药物洗脱支架在心血管系统疾病的治疗中已处于临床使用阶段,消化道药物洗脱支架目前处于研制及动物实验阶段;镁合金可降解支架已经在心血管系统广泛应用。随着生物工程材料的发展,药物镁合金可降解支架已成为食管支架研究的热点和前沿。本文对药物镁合金可降解支架研发的现状和展望进行全面详细阐述,重点介绍支架工艺:支架成型,覆膜改性,载药处理。

参考文献/References:

[1] Zhao JG, Li YD, Cheng YS, et al. Long term safety and outcome of a temporary self expanding metallic stent for achalasia: a prospective study with a 13 year single center experience[J]. Eur Radiol, 2009, 19: 1973 1980.
[2] Li YD, Tang GY, Cheng YS, et al. 13 year follow up of a prospective comparison of the long term clinical efficacy of temporary self expanding metallic stents and pneumatic dilatation for the treatment of achalasia in 120 patients[J]. AJR Am J Roentgenol, 2010, 195: 1429 1437.
[3] Zhu YQ, Cheng YS, Li F, et al. Application of the newly developed stents in the treatment of benign cardia stricture: an experimental comparative study[J]. Gastrointest Endosc, 2011, 73: 329 337.
[4] Zhu YQ, Cheng YS, Li MH, et al. Temporary self expanding cardia stents for the treatment of achalasia: an experimental study in dogs[J]. Neurogastroenterol Motil, 2010, 22: 1240 1247, e321 e322.
[5] Wassef W, Syed I. Designer stents: are we there yet?[J]. Gas trointest Endosc. 2007, 66: 804 808.
[6] Singh SS, Roy A, Lee BE. A study of Strontium doped Calcium phosphate coatings on AZ31[J]. Mater Sci Eng C Mater Biol Appl, 2014: 357 365.
[7] Lu P, Cao L, Liu Y, et al. Evaluation of Magnesium ions release, biocorrosion, and hemocompatibility of MAO/PLLA modified Magnesium alloy WE42[J]. J Biomed Mater Res B Appl Biomater, 2011, 96: 101 109.
[8] 殷 毅, 张 强, 齐峥嵘, 等. 微弧氧化ZK60镁合金生物安全性和降解性的体内实验研究[J]. 中国骨伤, 2013, 26: 423 428.
[9] 席玉胜. 可降解心血管支架材料发展的优势与趋势[J]. 中国组织工程研究与临床康复, 2010, 14: 6397 6400.
[10]朱悦琦, 程英升, 李明华. 生物可降解支架在良性管腔狭窄成形术中应用的研究进展[J]. 介入放射学杂志, 2008, 17: 675 680.
[11] Waksman R, Erbel R, Di Mario C, et al. Early and long term intravascular ultrasound and angiographic findings after bioabsorbable Magnesium stent implantation in human coronary arteries[J]. JACC Cardiovasc Interv, 2009, 2: 312 320.
[12] Jagur Grodzinski J. Polymers for tissue engineering, medical devices, and regenerative medicine. Concise general review of recent studies[J]. Polym Adv Technol, 2006, 17: 395 418.
[13]李 菁, 陈大凯, 任 杰. 聚乳酸立构复合物的研究最新进展与应用展望[J]. 高分子通报, 2011: 33 39.
[14] Lorenzo Zú?觡iga V, Moreno De Vega V, Marín I, et al. Biodegradable stents in gastrointestinal endoscopy[J]. World J Gastroenterol, 2014, 20: 2212 2217.
[15] Wu Q, Zhu S, Wang L, et al. The microstructure and properties of cyclic extrusion compression treated Mg Zn Y Nd alloy for vascular stent application[J]. J Mech Behav Biomed Mater, 2012, 8: 1 7.
[16]张 晓, 梁敏洁, 廖海洪, 等. 生物医用镁合金腐蚀与防护的研究进展[J]. 热加工工艺, 2014, 43: 9 12.
[17]李 涛, 张海龙, 何 勇, 等. 生物医用镁合金研究进展[J]. 功能材料, 2013, 44: 2913 2918.
[18]金耀华, 高 巍, 王正品, 等. 可降解稀土镁合金模拟血管支架腐蚀研究[J]. 稀土, 2013, 34: 31 34.
[19]曾荣昌, 孔令鸿, 陈 君, 等. 医用镁合金表面改性研究进展[J]. 中国有色金属学报, 2011, 21: 35 43.
[20]陈 宏, 郝建民. 医用镁合金ZrO2陶瓷膜制备及其骨生物活性研究[J]. 稀有金属材料与工程, 2014, 45: 150 153.
[21] 赵晓鑫, 马 颖, 孙 钢. 镁合金微弧氧化研究进展[J]. 铸造技术, 2013, 36: 45 47.
[22] Peng Q, Li K, Han Z, et al. Degradable magnesium based implant materials with anti inflammatory activity[J]. J Biomed Mater Res A, 2013, 101: 1898 1906.
[23] 王精兵, 程永德. 重视覆膜支架在外周血管病中的应用[J]. 介入放射学杂志, 2007, 16: 577 579.
[24]黄莹莹, 齐 民, 杨大智, 等. 冠脉支架表面PLGA涂层制备及其血液相容性研究[J]. 功能材料, 2006, 37: 411 414.
[25] Yamawaki T, Shimokawa H, Kozai T, et al. Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo[J]. J Am Coll Cardiol, 1998, 32: 780 786.
[26] Khandare J, Minko T. Polymer drug conjugates: Progress in polymeric prodrugs[J]. Prog Polym Sci, 2006, 31: 359 397.
[27] Ribichini F, Tomai F, Paloscia L, et al. Steroid eluting stents in patients with acute coronary syndrome: the dexamethasone eluting stent Italian registry[J]. Heart, 2007, 93: 598 600.
[28] Han SH, Ahn TH, Kang WC, et al. The favorable clinical and angiographic outcomes of a high dose dexamethasone eluting stent: randomized controlled prospective study[J]. Am Heart J, 2006, 152: 887.e1 e7.
[29] Wang R, Ghahary A, Shen Q, et al. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor beta1 mRNA and protein than normal skin and cells[J]. Wound Repair Regen, 2000, 8: 128 137.
[30] van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries[J]. Circulation, 1996, 94: 1690 1697.
[31] Kaparissides C, Alexandridou S, Kotti K, et al. Recent advances in novel drug delivery systems[J]. Int J Pharm Tech Res, 2010, 2: 2025 2027.
[32] Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: drug eluting stents: Part I[J]. Circulation, 2003, 107: 2274 2279.
[33] Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project[J]. J Am Coll Cardiol, 2006, 47: 175 181.

相似文献/References:

[1]单 明,王传卓,畅智慧,等. 食管支架致上消化道大出血的危险因素[J].介入放射学杂志,2012,(02):131.
 SHAN Ming,WANG Chuan-zhuo,CHANG Zhi-hui,et al.Risk factors of upper digestive tract massive bleeding caused by esophageal stent placement[J].journal interventional radiology,2012,(05):131.
[2]赖光湖,窦 娟,吴小明,等.125I放射性粒子食管支架治疗进展期食管癌的生活质量评价[J].介入放射学杂志,2018,27(09):842.
 LAI Guanghu,DOU Juan,WU Xiaoming,et al.Implantation of esophageal stent carrying 125I radioactive seeds for the treatment of advanced esophageal cancer: evaluation of patient’s quality of life[J].journal interventional radiology,2018,27(05):842.

备注/Memo

备注/Memo:
(收稿日期:2014-07-12)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2015-05-19